
Optimizing Mycoplasma Detection: The Benefits of DNA-Based Testing
Fill out the form below and we'll send your colleague an invitation to the "Optimizing Mycoplasma Detection: The Benefits of DNA-Based Testing" event.
Mycoplasma contamination in biopharmaceutical production is a critical concern, with significant implications for both product safety and efficacy.
This webinar explores the use of DNA as an advanced analyte for Mycoplasma testing, providing an in-depth comparison between traditional approaches and molecular methods.
Our expert speaker will outline the benefits and broader applications of DNA analysis, including technology transfer and other critical processes in biopharmaceutical manufacturing.
Attendees will also gain insights into how to implement DNA-based testing in manufacturing processes.
Attend this webinar to:
- Understand the differences in Mycoplasma testing approaches
- Gain an overview of how DNA serves as a robust biological marker for the presence of Mycoplasma
- Explore practical applications of DNA-based testing facilitating Mycoplasma testing

